1
|
Kuebler B, Alvarez-Palomo B, Aran B, Castaño J, Rodriguez L, Raya A, Querol Giner S, Veiga A. Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population. Stem Cell Res Ther 2023; 14:366. [PMID: 38093328 PMCID: PMC10720139 DOI: 10.1186/s13287-023-03576-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Accepted: 11/16/2023] [Indexed: 12/17/2023] Open
Abstract
BACKGROUND Induced pluripotent stem cell (iPSC)-derived cell therapies are an interesting new area in the field of regenerative medicine. One of the approaches to decrease the costs of iPSC-derived therapies is the use of allogenic homozygous human leukocyte antigen (HLA)-matched donors to generate iPSC lines and to build a clinical-grade iPSC bank covering a high percentage of the Spanish population. METHODS The Spanish Stem Cell Transplantation Registry was screened for cord blood units (CBUs) homozygous for the most common HLA-A, HLA-B and HLA-DRB1 haplotypes. Seven donors were selected with haplotypes covering 21.37% of the haplotypes of the Spanish population. CD34-positive hematopoietic progenitors were isolated from the mononuclear cell fraction of frozen cord blood units from each donor by density gradient centrifugation and further by immune magnetic labeling and separation using purification columns. Purified CD34 + cells were reprogrammed to iPSCs by transduction with the CTS CytoTune-iPS 2.1 Sendai Reprogramming Kit. RESULTS The iPSCs generated from the 7 donors were expanded, characterized, banked and registered. Master cell banks (MCBs) and working cell banks (WCBs) from the iPSCs of each donor were produced under GMP conditions in qualified clean rooms. CONCLUSIONS Here, we present the first clinical-grade, iPSC haplobank in Spain made from CD34 + cells from seven cord blood units homozygous for the most common HLA-A, HLA-B and HLA-DRB1 haplotypes within the Spanish population. We describe their generation by transduction with Sendai viral vectors and their GMP-compliant expansion and banking. These haplolines will constitute starting materials for advanced therapy medicinal product development (ATMP).
Collapse
Affiliation(s)
- B Kuebler
- Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain
- Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain
| | - B Alvarez-Palomo
- Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain
| | - B Aran
- Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain
- Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain
| | - J Castaño
- Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain
- Advanced Therapy Platform, Hospital Sant Joan de Déu de Barcelona, Pg. de Sant Joan de Déu, 2, Espluges de Llobregat, 08950, Barcelona, Spain
| | - L Rodriguez
- Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain
| | - A Raya
- Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
- Stem Cell Potency Group, Regenerative Medicine Program, Institut d´Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
- Centre for Networked Biomedical Research On Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
- Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain.
| | - S Querol Giner
- Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain.
- Transfusional Medicine Group, Vall d'Hebron Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain.
| | - A Veiga
- Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
- Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
| |
Collapse
|
2
|
Chitta LP, Zhukov AN, Berghmans D, Peter H, Parenti S, Mandal S, Aznar Cuadrado R, Schühle U, Teriaca L, Auchère F, Barczynski K, Buchlin É, Harra L, Kraaikamp E, Long DM, Rodriguez L, Schwanitz C, Smith PJ, Verbeeck C, Seaton DB. Picoflare jets power the solar wind emerging from a coronal hole on the Sun. Science 2023; 381:867-872. [PMID: 37616348 DOI: 10.1126/science.ade5801] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Accepted: 07/14/2023] [Indexed: 08/26/2023]
Abstract
Coronal holes are areas on the Sun with open magnetic field lines. They are a source region of the solar wind, but how the wind emerges from coronal holes is not known. We observed a coronal hole using the Extreme Ultraviolet Imager on the Solar Orbiter spacecraft. We identified jets on scales of a few hundred kilometers, which last 20 to 100 seconds and reach speeds of ~100 kilometers per second. The jets are powered by magnetic reconnection and have kinetic energy in the picoflare range. They are intermittent but widespread within the observed coronal hole. We suggest that such picoflare jets could produce enough high-temperature plasma to sustain the solar wind and that the wind emerges from coronal holes as a highly intermittent outflow at small scales.
Collapse
Affiliation(s)
- L P Chitta
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - A N Zhukov
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
- Skobeltsyn Institute of Nuclear Physics, Moscow State University, Moscow 119991, Russia
| | - D Berghmans
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
| | - H Peter
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - S Parenti
- Institut d'Astrophysique Spatiale, Centre National de la Recherche Scientifique, Université Paris-Saclay, 91405 Orsay, France
| | - S Mandal
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - R Aznar Cuadrado
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - U Schühle
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - L Teriaca
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - F Auchère
- Institut d'Astrophysique Spatiale, Centre National de la Recherche Scientifique, Université Paris-Saclay, 91405 Orsay, France
| | - K Barczynski
- Physikalisch-Meteorologisches Observatorium Davos, World Radiation Center, 7260 Davos Dorf, Switzerland
- Eidgenössische Technische Hochschule Zürich, 8093 Zürich, Switzerland
| | - É Buchlin
- Institut d'Astrophysique Spatiale, Centre National de la Recherche Scientifique, Université Paris-Saclay, 91405 Orsay, France
| | - L Harra
- Physikalisch-Meteorologisches Observatorium Davos, World Radiation Center, 7260 Davos Dorf, Switzerland
- Eidgenössische Technische Hochschule Zürich, 8093 Zürich, Switzerland
| | - E Kraaikamp
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
| | - D M Long
- Mullard Space Science Laboratory, University College London, Dorking, Surrey RH5 6NT, UK
- Astrophysics Research Centre, School of Mathematics and Physics, Queen's University Belfast, Belfast BT7 1NN, Northern Ireland, UK
| | - L Rodriguez
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
| | - C Schwanitz
- Physikalisch-Meteorologisches Observatorium Davos, World Radiation Center, 7260 Davos Dorf, Switzerland
- Eidgenössische Technische Hochschule Zürich, 8093 Zürich, Switzerland
| | - P J Smith
- Mullard Space Science Laboratory, University College London, Dorking, Surrey RH5 6NT, UK
| | - C Verbeeck
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
| | - D B Seaton
- Southwest Research Institute, Boulder, CO 80302, USA
| |
Collapse
|
3
|
Cheng X, Priest ER, Li HT, Chen J, Aulanier G, Chitta LP, Wang YL, Peter H, Zhu XS, Xing C, Ding MD, Solanki SK, Berghmans D, Teriaca L, Aznar Cuadrado R, Zhukov AN, Guo Y, Long D, Harra L, Smith PJ, Rodriguez L, Verbeeck C, Barczynski K, Parenti S. Author Correction: Ultra-high-resolution observations of persistent null-point reconnection in the solar corona. Nat Commun 2023; 14:2372. [PMID: 37185588 PMCID: PMC10130028 DOI: 10.1038/s41467-023-38149-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/17/2023] Open
Affiliation(s)
- X Cheng
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China.
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany.
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China.
| | - E R Priest
- School of Mathematics and Statistics, University of St. Andrews, Fife, KY16 9SS, Scotland, UK
| | - H T Li
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - J Chen
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - G Aulanier
- Sorbonne Université, Observatoire de Paris - PSL, École Polytechnique, IP Paris, CNRS, Laboratory for Plasma Physics (LPP), 4 place Jussieu, 75005, Paris, France
- Rosseland Centre for Solar Physics, Institute for Theoretical Astrophysics, Universitetet i Oslo, P.O. Box 1029, Blindern, 0315, Oslo, Norway
| | - L P Chitta
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - Y L Wang
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - H Peter
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - X S Zhu
- State Key Laboratory of Space Weather, National Space Science Center, Chinese Academy of Sciences, Beijing, China
| | - C Xing
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Sorbonne Université, Observatoire de Paris - PSL, École Polytechnique, IP Paris, CNRS, Laboratory for Plasma Physics (LPP), 4 place Jussieu, 75005, Paris, France
| | - M D Ding
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - S K Solanki
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - D Berghmans
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - L Teriaca
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - R Aznar Cuadrado
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - A N Zhukov
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
- Skobeltsyn Institute of Nuclear Physics, Moscow State University, 119992, Moscow, Russia
| | - Y Guo
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - D Long
- Mullard Space Science Laboratory, University College London, Holmbury St. Mary, Dorking, Surrey, RH5 6NT, UK
| | - L Harra
- PMOD/WRC, Dorfstrasse 33, CH-7260, Davos Dorf, Switzerland
- ETH-Zürich, Wolfang-Pauli-Strasse 27, HIT J 22.4, 8093, Zürich, Switzerland
| | - P J Smith
- Mullard Space Science Laboratory, University College London, Holmbury St. Mary, Dorking, Surrey, RH5 6NT, UK
| | - L Rodriguez
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - C Verbeeck
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - K Barczynski
- ETH-Zürich, Wolfang-Pauli-Strasse 27, HIT J 22.4, 8093, Zürich, Switzerland
| | - S Parenti
- Institut d'Astrophysique Spatiale, Université Paris-Saclay, 91405, Orsay Cedex, France
| |
Collapse
|
4
|
Cheng X, Priest ER, Li HT, Chen J, Aulanier G, Chitta LP, Wang YL, Peter H, Zhu XS, Xing C, Ding MD, Solanki SK, Berghmans D, Teriaca L, Aznar Cuadrado R, Zhukov AN, Guo Y, Long D, Harra L, Smith PJ, Rodriguez L, Verbeeck C, Barczynski K, Parenti S. Ultra-high-resolution observations of persistent null-point reconnection in the solar corona. Nat Commun 2023; 14:2107. [PMID: 37055427 PMCID: PMC10102217 DOI: 10.1038/s41467-023-37888-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Accepted: 03/30/2023] [Indexed: 04/15/2023] Open
Abstract
Magnetic reconnection is a key mechanism involved in solar eruptions and is also a prime possibility to heat the low corona to millions of degrees. Here, we present ultra-high-resolution extreme ultraviolet observations of persistent null-point reconnection in the corona at a scale of about 390 km over one hour observations of the Extreme-Ultraviolet Imager on board Solar Orbiter spacecraft. The observations show formation of a null-point configuration above a minor positive polarity embedded within a region of dominant negative polarity near a sunspot. The gentle phase of the persistent null-point reconnection is evidenced by sustained point-like high-temperature plasma (about 10 MK) near the null-point and constant outflow blobs not only along the outer spine but also along the fan surface. The blobs appear at a higher frequency than previously observed with an average velocity of about 80 km s-1 and life-times of about 40 s. The null-point reconnection also occurs explosively but only for 4 minutes, its coupling with a mini-filament eruption generates a spiral jet. These results suggest that magnetic reconnection, at previously unresolved scales, proceeds continually in a gentle and/or explosive way to persistently transfer mass and energy to the overlying corona.
Collapse
Affiliation(s)
- X Cheng
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China.
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany.
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China.
| | - E R Priest
- School of Mathematics and Statistics, University of St. Andrews, Fife, KY16 9SS, Scotland, UK
| | - H T Li
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - J Chen
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - G Aulanier
- Sorbonne Université, Observatoire de Paris - PSL, École Polytechnique, IP Paris, CNRS, Laboratory for Plasma Physics (LPP), 4 place Jussieu, 75005, Paris, France
- Rosseland Centre for Solar Physics, Institute for Theoretical Astrophysics, Universitetet i Oslo, P.O. Box 1029, Blindern, 0315, Oslo, Norway
| | - L P Chitta
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - Y L Wang
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - H Peter
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - X S Zhu
- State Key Laboratory of Space Weather, National Space Science Center, Chinese Academy of Sciences, Beijing, China
| | - C Xing
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Sorbonne Université, Observatoire de Paris - PSL, École Polytechnique, IP Paris, CNRS, Laboratory for Plasma Physics (LPP), 4 place Jussieu, 75005, Paris, France
| | - M D Ding
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - S K Solanki
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - D Berghmans
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - L Teriaca
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - R Aznar Cuadrado
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - A N Zhukov
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
- Skobeltsyn Institute of Nuclear Physics, Moscow State University, 119992, Moscow, Russia
| | - Y Guo
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - D Long
- Mullard Space Science Laboratory, University College London, Holmbury St. Mary, Dorking, Surrey, RH5 6NT, UK
| | - L Harra
- PMOD/WRC, Dorfstrasse 33, CH-7260, Davos Dorf, Switzerland
- ETH-Zürich, Wolfang-Pauli-Strasse 27, HIT J 22.4, 8093, Zürich, Switzerland
| | - P J Smith
- Mullard Space Science Laboratory, University College London, Holmbury St. Mary, Dorking, Surrey, RH5 6NT, UK
| | - L Rodriguez
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - C Verbeeck
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - K Barczynski
- ETH-Zürich, Wolfang-Pauli-Strasse 27, HIT J 22.4, 8093, Zürich, Switzerland
| | - S Parenti
- Institut d'Astrophysique Spatiale, Université Paris-Saclay, 91405, Orsay Cedex, France
| |
Collapse
|
5
|
Caruana E, Salomon J, Rodriguez L, Boutoille D. Descriptive management of suspected acute cystitis in adult patients by French general practitioners during remote consultation. Infect Dis Now 2023; 53:104707. [PMID: 37044246 DOI: 10.1016/j.idnow.2023.104707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Revised: 03/15/2023] [Accepted: 04/01/2023] [Indexed: 04/14/2023]
Abstract
OBJECTIVES The main objective of this study was to analyze French general practitioners' (GP) online prescriptions for suspected acute cystitis using a single nationwide teleconsultation platform. PATIENTS AND METHODS First, a descriptive study of management for suspected cystitis was conducted from the 1st of January to the 31st of December 2020. After which, following pedagogical intervention, a pre/post descriptive analysis of the antibiotics prescribed was carried out. RESULTS Some 496,041 teleconsultations (TCs) were carried out in 2020 on the Qare platform. Among them, 15089 TCs for cystitis with ICD-10 encoding (N30) were analyzed. Fosfomycin trometamol was the most prescribed antibiotic (n=10297, 69%), while fluoroquinolones (n=1568, 10.6%) were the second. Urine test strip was prescribed in 3157 (20%) and urine culture in 7033 (47%) of the TCs. July-August 2020 and July-August 2021 were compared and while a significant drop in fluoroquinolone prescriptions and a major increase in Fosfomycin trometamol were observed, there was no change in the prescriptions of urine culture. An average antibiotic conformity rate of 61.5% was observed before the intervention, and 68.8% afterwards. CONCLUSIONS Cystitis is a recurrent reason for remote consultation. The study demonstrated sizable over-prescription of urine culture, ultrasound, and fluoroquinolones. Intervention should be improved and strengthened to guarantee continuous training and awareness of GP's on appropriate cystitis prescriptions in telemedicine.
Collapse
Affiliation(s)
- E Caruana
- Cabinet de médecine générale, 56 Rue Charles Rivière, 44400 Rezé 75008 Paris
| | - J Salomon
- Pédiatre MD, PhD, Directrice Médicale Adjointe Qare, Référente Médicale Formation et Qualité, 36, avenue Pierre 1er de Serbie 75008 Paris
| | - L Rodriguez
- Infirmier Support et Formation Qare. 36 Avenue Pierre 1er de Serbie
| | - D Boutoille
- Infectiologue CHU de Nantes, CHU de Nantes, 1 place Alexis Ricordeau 44093, Nantes
| |
Collapse
|
6
|
Flores J, Moreno C, Moriarty A, Papadopoulos K, Drengler R, Rodriguez L, Salih H, Rasco D, Patnaik A, Wick M. Establishment and characterization of HPV+ metastatic squamous cell anal carcinoma XPDX models in athymic nude mice. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00837-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
7
|
Melot B, Amsilli M, Drouet F, Rodriguez L, Salomon J, Grosjean J, Duclos C. Appropriateness of Antibiotic Prescription During Teleconsultation. Stud Health Technol Inform 2022; 298:142-146. [PMID: 36073473 DOI: 10.3233/shti220924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Teleconsultation has become a new means of using care which has taken off significantly since the COVID crisis, The pooling of the technological environment within the TC makes it possible to set up practice reviews by reusing the data collected. Our aim was to evaluate the relevance of antibiotic therapy during teleconsultations carried out on the national teleconsultation platform "Qare" in 4 common infections. 143,428 TCs with structured prescriptions were analyzed, with an appropriate prescription in more than 82% of cases, higher than in the literature. The use of data makes it possible to quickly assess practices and inform doctors to improve their practices.
Collapse
Affiliation(s)
- B Melot
- Qare, Paris, France
- Université Sorbonne Paris Nord, Laboratoire d'Informatique Médicale et d'Ingénierie des connaissances en e-Santé, LIMICS, Sorbonne Université, INSERM, F-93000, Bobigny, France
| | | | | | | | | | - J Grosjean
- Université Sorbonne Paris Nord, Laboratoire d'Informatique Médicale et d'Ingénierie des connaissances en e-Santé, LIMICS, Sorbonne Université, INSERM, F-93000, Bobigny, France
- Department of Digital Health, Rouen University Hospital, Rouen France
| | - C Duclos
- Université Sorbonne Paris Nord, Laboratoire d'Informatique Médicale et d'Ingénierie des connaissances en e-Santé, LIMICS, Sorbonne Université, INSERM, F-93000, Bobigny, France
| |
Collapse
|
8
|
Gordillo Montaño M, Boned Torres S, Rodriguez L. Psycho-Covid. Eur Psychiatry 2022. [PMCID: PMC9568099 DOI: 10.1192/j.eurpsy.2022.1353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction The COVID-19 pandemic generated a health emergency and led to the adoption of different measures, including home quarantine and social isolation, which, as we have seen, has had an impact on the mental health of the majority of citizens, with the possibility of psychiatric disorders appearing. in people without prior mental illness, such as acute decompensations in patients with known disorders, more vulnerable to environmental stressors. Objectives Learn and rethink alarm signals in extreme situations such as the one experienced in recent months, as well as observe the impact, negative in many cases, but positive in others, of the patients we treat daily. Methods Description through brief clinical cases of the impact of the COVID-19 pandemic on psychotic patients and the decompensation that it has entailed, including due to confinement measures and social isolation, associated with over-information through the media, chaos initial and the uncertainty that it caused and the associated fear. Results Restrictions as a result of COVID-19 have played a very relevant role as an external stressor for the appearance of psychopathological alterations, including psychotic symptoms. In addition, people who suffer from psychosis or at risk of psychotic disorder can be especially affected and trigger acute psychopathology with social isolation, loss of daily routines, unemployment, homelessness. Conclusions These cases are an example that shows the need for an early and effective approach to the rise in mental illnesses in circumstances of this caliber. Disclosure No significant relationships.
Collapse
|
9
|
Pavía Pascual M, Pérez S, Rodriguez L, Ruiz Antorán B, Rusinovich O, de la Torre Rubio N, Machattou M, Navarro Palomo P, Campos Esteban J, Fernandez Castro M, Godoy H, Barbadillo Mateos C, Merino Argumánez C, Espinosa M, Garcia-Magallon B, Calleja Panero JL, Andréu Sánchez JL, Sanz J. AB0802 PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, AND PSORIATIC ARTHRITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.2043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundNon-alcoholic fatty liver disease (NAFLD), the most common cause of liver disease, has a prevalence of about 25% in the general population. It increases mortality and comorbidity in patients with immune-mediated inflammatory diseases.ObjectivesThe main objective is to estimate the prevalence of NAFLD in three of the most common rheumatologic pathologies: rheumatoid arthritis (RA), axial spondyloarthritis (SpA-ax) and psoriatic arthritis (PsA). As a secondary objective, the possibility of finding associated risk factors in this group of subjects that may imply a higher risk of developing NAFLD is proposed.MethodsWe conducted a prospective single center observational study which included patients diagnosed with RA, EspA-ax, and PsA attended in the Rheumatology department of a tertiary hospital from January to April 2021. Anthropometric parameters, history related to cardiovascular risk factors and disease activity at the time of the visit were collected. Additionally, blood tests and transitional elastography were performed in all patients and the presence of NAFLD was assessed by the fatty liver index (FLI) scale. Different variables were considered to study their association with NAFLD.Results90 patients were included: 28 diagnosed with RA, 36 with EspA-ax and 26 with PAs. 41.1% were male (age range: 27-79 years). Patients with previous liver disease were excluded from the study. 22 (27.2%) patients had NAFLD measured by FLI ≥ 60. No significant differences in prevalence of hepatic steatosis were found between the 3 groups, although values were higher in patients with PsA.The variables that were significantly associated with the development of NAFLD in our cohort were: body mass index (BMI), abdominal perimeter, blood glucose level, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), HDL, TG, GGT, ferritin and uric acid levels. The rest of the variables studied did not show statistically significant differences (Table 1).Table 1.NO STEATOSIS (FLI<60)n=59STEATOSIS (FLI>60)n=22MeanStandard deviationMeanStandard deviationpBMI24,523,0030,292,77< 0,001Abdominal perimeter86,3410,01106,828,55< 0,001Age52,9312,8757,598,240,1185Glucose78,648,3790,6419,690,0002Insulin8,8310,1212,406,660,1302HOMA1,752,022,761,700,0500HbA1c5,350,455,690,640,0096Total cholesterol190,9829,46201,4138,530,1977HDL64,8817,6655,5911,550,0249LDL110,4428,45120,0036,210,2163TG81,1232,42128,5055,52< 0,001GPT25,8330,7337,1819,820,1116GOT27,2023,4926,8210,690,9413GGT20,8017,6649,9538,46< 0,001Creatinin0,750,190,840,180,0583Uric acid4,781,305,911,140,0007Ferritina121,75111,30208,00140,170,0050PCR2,894,552,672,330,8307ConclusionHepatic steatosis was present in 27.2% of patients vs 25% estimated prevalence in the general population. Identification of risk factors involved would allow better control of the comorbidities associated with NAFLD.The fact that the prevalence found in our sample population is so close to that of the general population, may be related to a good inflammatory control of the underlying disease.Further prospective studies with larger sample sizes are needed to find additional predictive factors for the development of NAFLD in this group of diseases.References[1]Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A. y Tiribelli, C. (2006). The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology, 6: 33.[2]Brenner, C., Galluzzi, L., Kepp, O. y Kroemer, G. (2013). Decoding cell death signals in liver inflammation. Journal of Hepatology, 59(3): 583-594.[3]Byrne, C.D. y Targher, G. (2015). NAFLD: a multisystem disease. Journal of Hepatology, 62(1 Suppl): 47[4]Miele, L., Vallone, S., Cefalo, C., La Torre, G., Di Stasi, C., Vecchio, F.M., et al. (2009). Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. Journal of Hepatology, 51(4): 778-786.Disclosure of InterestsNone declared
Collapse
|
10
|
Emenaker N, Rodriguez L. Incorporating Dietary Supplement Use into Client Care Practices: An Oncology Example. J Acad Nutr Diet 2021. [DOI: 10.1016/j.jand.2021.06.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
11
|
Linares Galiana I, Garcia Exposito N, Plana M, Brenes J, Oliva M, Nogues J, Cos M, Rodriguez L, Tornero J, Mora P, Lozano A. PO-0960 Long-term outcome of IMRT-SIB and chemotherapy in nasopharyngeal carcinoma in a nonendemic area. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07411-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
12
|
Wang T, Flamm S, Schoenhagen P, Griffin B, Rodriguez L, Grimm R, Xu B. Diagnostic And Prognostic Performance Of Aortic Valve Calcium Score By Cardiac Computed Tomography For Severe Aortic Stenosis: A Meta-analysis. J Cardiovasc Comput Tomogr 2021. [DOI: 10.1016/j.jcct.2021.06.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
13
|
Pieruzzini R, Ayala-Grosso C, de Jesus Navas J, Rodriguez W, Parra N, Luque E, Sanchez-Gago A, Gonzalez S, Hagobian A, Grullon A, Diaz K, Morales M, De Jesus M, Pena S, Rodriguez L, Pena L, Asaro A, Magris M. What smell and taste disorders by SARS-CoV-2 do we know? Predictive value of the Venezuelan Olfactory Test and RT-PCR molecular analysis in COVID-19 infection. RHINOL 2021. [DOI: 10.4193/rhinol/21.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Background: Smell and taste disorders are reported very frequently and at an early stage in SARS-CoV-2 infectious disease. These symptoms could be sensitive and specific to establish possible severity of the infection, and may suggest the flow of decisions as to further therapy. Objective: We asked whether smell and taste impairment are earlier and more sensitive symptoms than the RT-PCR molecular assays for SARS-CoV-2 detection. Methods: Subjects (N=275) with a probable COVID-19 diagnosis were classified as follows: Symptomatic with chemosensory dysfunction, symptomatic without chemosensory dysfunction, and asymptomatic. Validated unbiased testing of the chemosensory dysfunction was performed by means of the Venezuelan Olfactory Test and taste test. Nasal swabs and blood samples were analyzed by RT-PCR molecular analysis a rapid diagnostic test to detect the SARS-CoV-2 virus and viral antibodies, respectively. Smell and taste testing and RT-PCR were performed every 3 to 5 days to patients until full recovery. Results: Out of 144 patients that were positive for SARS-CoV-2: 45.83% had COVID-19 symptoms, smell and taste disorders; 23.61% had COVID-19 symptoms but not smell or taste disorders, and 30.55% were asymptomatic. Mild hyposmia and hypogeusia were frequently associated with SARS-CoV-2 symptoms. Recovery from chemosensory dysfunction occurred between day 3 and 14. RT-PCR becomes negative after 21 days. The Venezuelan Olfactory Test and taste test has a 61.68% positive predictive value, 45.83% sensitivity, and 68.7% specificity for SARS-CoV-2. Conclusions: Smell and taste disorders are associated symptoms with SARS-CoV-2 infection, but not a predictor of the disease, as compared to the molecular RT-PCR test.
Collapse
|
14
|
Torrents-Zapata S, Aran G, Codinach M, Blanco M, Soria G, Rodriguez L, Querol S, Vives J. Design and validation of an improved immunopotency assay for product release of mesenchymal stromals cell-based therapeutics in accordance to good manufacturing practices. Cytotherapy 2021. [DOI: 10.1016/s146532492100596x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
15
|
Munera-Campos M, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, Sahuquillo-Torralba A, Gómez-García FJ, Baniandrés-Rodríguez O, de la Cueva P, López-Estebaranz JL, Belinchón I, Ferran M, Riera-Monroig J, Rodriguez L, Carretero G, García-Donoso C, Ballescá F, Llamas-Velasco M, Herrera-Ceballos E, Pujol-Marco C, Nieto-Benito LM, Ruiz-Genao DP, Alsina M, Descalzo MA, García-Doval I. The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry. J DERMATOL TREAT 2021; 33:2110-2117. [PMID: 33913796 DOI: 10.1080/09546634.2021.1922572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
BACKGROUND Limited information is available regarding the risk of incident liver disease in patients with psoriasis receiving systemic therapies. OBJECTIVES To describe the liver safety findings of conventional and modern systemic therapies for moderate-to-severe psoriasis, and to compare the relative incidence rates of hepatic adverse events (AEs) for each drug. METHODS All the patients on the BIOBADADERM registry were included. Crude and adjusted incidence rate ratios (cIRR and aIRR, respectively) of hepatic AEs, using anti-TNF drugs as reference, were determined. Outcomes of interest were hypertransaminasemia, nonalcoholic fatty liver disease (NADFLD) and a group of other, less represented, hepatic AEs. RESULTS Our study included 3,171 patients exposed to systemic drugs (6279 treatment cycles). Incident hypertransaminasemia was the most frequent hepatic AE (incidence rate of 21 per 1000 patients-years [CI 95% CI 18-23]), followed by NAFLD (8 cases per 1000 patients-years [95% CI 6-10]). Methotrexate (aIRR 3.06 [2.31-4.4]; p = 0.000) and cyclosporine (aIRR 2.37 [1.05-5.35]; p = 0.0378) were associated with an increased risk for hypertransaminasemia when compared to anti-TNF-α agents. No differences were observed between different groups of biologics. Conventional therapies were not associated with new incident NAFLD. CONCLUSIONS Comparative information of the incidence of hepatic AEs could facilitate drug selection in moderate-to-severe psoriasis.
Collapse
Affiliation(s)
- M Munera-Campos
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - J Vilar-Alejo
- Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
| | - R Rivera
- Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - J M Carrascosa
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - E Daudén
- Department of Dermatology. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain
| | - E Herrera-Acosta
- Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - A Sahuquillo-Torralba
- Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - F J Gómez-García
- Department of Dermatology, Hospital Universitario Reina Sofía, Cordoba, Spain
| | - O Baniandrés-Rodríguez
- Department of Dermatology, CEIMI Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - P de la Cueva
- Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain
| | - J L López-Estebaranz
- Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - I Belinchón
- Department of Dermatology, Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain
| | - M Ferran
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
| | - J Riera-Monroig
- Department of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona, Spain
| | - L Rodriguez
- Department of Dermatology, Hospital Virgen del Rocío, Sevilla, Spain
| | - G Carretero
- Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
| | - C García-Donoso
- Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - F Ballescá
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - M Llamas-Velasco
- Department of Dermatology. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain
| | - E Herrera-Ceballos
- Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - C Pujol-Marco
- Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - L M Nieto-Benito
- Department of Dermatology, CEIMI Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - D P Ruiz-Genao
- Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - M Alsina
- Department of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona, Spain
| | - M A Descalzo
- Research Unit. Fundación Piel Sana AEDV, Madrid, Spain
| | - I García-Doval
- Research Unit. Fundación Piel Sana AEDV, Madrid, Spain.,Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | | |
Collapse
|
16
|
Stewart S, King F, Rodriguez L, Meier S, Sherry S, Abbass A, Deacon H, Nogueira-Arjona R, Hagen A. The effects of excessive and compulsive online searching of COVID-19 information (“cyberchondria”) on general and COVID-19-specific anxiety and fear in romantic couples during lockdown. Eur Psychiatry 2021. [PMCID: PMC9471794 DOI: 10.1192/j.eurpsy.2021.792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Introduction Cyberchondria involves excessive and uncontrollable online searching of information about a perceived illness. This behavior can cause or maintain distress. Objectives Little is known about cyberchondria during the COVID-19 pandemic or how cyberchondria in one individual may cause distress in their significant other if they are self-isolating together; our study sought to fill these gaps. Methods We conducted a Qualtrics Panel survey with 760 cohabitating Canadian couples; in June 2020, participants retrospectively reported on their cyberchondria behavior, general anxiety, and COVID-19 fears during the month of April 2020, while adhering to stay-at-home advisories. Two separate actor-partner interdependence models (APIMs) used cyberchondria excessiveness and compulsion to predict generalized anxiety and COVID-19 danger/contamination fears in the actor and partner. Results Both cyberchondria excessiveness and compulsion were associated with higher general anxiety and higher COVID-19 danger/contamination fears in the individual (actor effects). Partner cyberchondria compulsion was associated with higher general anxiety in the individual whereas partner cyberchondria excessiveness was associated with higher COVID-19 danger/contamination fears in the individual (partner effects). Conclusions Findings suggest that excessive and uncontrollable searching of information about COVID-19 on the internet during lockdown may contribute to distress in both the individual engaging in the cyberchondria behavior, and in their romantic partner. Moreover, different aspects of cyberchondria in the partner (compulsion vs. excessiveness) appears to contribute to general vs. COVID-19-specific anxiety/fears in the partner, respectively. Future research should examine mechanisms underlying the observed partner effects (e.g., co-rumination, social contagion) and reasons for the differential partner effects of cyberchondria components.
Collapse
|
17
|
Dreyfus I, Maza A, Rodriguez L, Merlos M, Texier H, Rousseau V, Sommet A, Mazereeuw-Hautier J. Botulinum toxin injections as an effective treatment for patients with intertriginous Hailey-Hailey or Darier disease: an open-label 6-month pilot interventional study. Orphanet J Rare Dis 2021; 16:93. [PMID: 33602313 PMCID: PMC7893874 DOI: 10.1186/s13023-021-01710-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Accepted: 01/21/2021] [Indexed: 11/04/2022] Open
Abstract
BACKGROUND Patients with Hailey-Hailey and Darier diseases present with disabling inflammatory lesions located in large skin folds, which are often exacerbated or induced by sweating. Quality of life is highly impaired because of pain and recurrent skin infections. An improvement in skin lesions after botulinum toxin A injections has previously been reported in some patients but no prospective interventional studies are available. The aim of this open-label, 6-month, interventional pilot study (NCT02782702) was to evaluate the effectiveness and safety of botulinum toxin A for patients with moderate to very severe skin lesions located in folds. RESULTS Thirty patients (26 Hailey-Hailey/4 Darier) were included. Botulinum toxin A proved effective within the first month in two-thirds of patients, taking all study parameters (itchiness, cutaneous pain, sweating and odour, infections, psychosocial impairment and quality of life) into account and persisted during the 6-month follow-up period. No patient was classed as a BtxA non-responder, but 11 (37%) Hailey-Hailey patients (the most severe ones), experienced a relapse during the study. No serious side effects were reported. Mild transient clear fluid discharge at the site of the injections was reported for 27% of patients. CONCLUSIONS Botulinic toxin seems to be an effective and safe treatment for Hailey-Hailey and Darier diseases. Nevertheless, it may prove insufficient for the severest of Hailey-Hailey cases and could be considered as supplementary to other conventional treatments. Further studies are required to confirm our results on larger Darier cohorts.
Collapse
Affiliation(s)
- Isabelle Dreyfus
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France.
| | - Aude Maza
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France
| | - Lauriane Rodriguez
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France
| | - Margot Merlos
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France
| | - Hélène Texier
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France
| | - Vanessa Rousseau
- Department of Clinical Pharmacology, CIC1436, University Hospital, Toulouse, France
| | - Agnès Sommet
- Department of Clinical Pharmacology, CIC1436, University Hospital, Toulouse, France
| | - Juliette Mazereeuw-Hautier
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France.,Paul Sabatier University, Toulouse, France
| |
Collapse
|
18
|
Fauste E, Rodrigo S, Rodriguez L, Donis C, Álvarez-Millan J, Panadero M, Otero P, Bocos C. Maternal fructose affects transsulfuration pathway of female progeny. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
19
|
Ruiz-Genao D, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Belinchón I, Gómez-García F, Herrera-Acosta E, López-Estebaranz J, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo J, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, García-Donoso C, Carrascosa J, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Descalzo M, García-Doval I. Cambios en las tendencias de la prescripción y causas de la interrupción en los tratamientos biológicos indicados en la psoriasis durante los primeros 10 años. Datos obtenidos del registro español Biobadaderm. Actas Dermo-Sifiliográficas 2020; 111:752-760. [DOI: 10.1016/j.ad.2020.05.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Accepted: 05/31/2020] [Indexed: 10/23/2022] Open
|
20
|
Ruiz-Genao D, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cuev P, Belinchón I, Gómez-García F, Herrera-Acosta E, López-Estebaranz J, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo J, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, García-Donoso C, Carrascosa J, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Descalzo M, García-Doval I. Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry. Actas Dermo-Sifiliográficas (English Edition) 2020. [DOI: 10.1016/j.adengl.2020.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
21
|
Kohut A, Kuhn T, Booher M, Naumova A, Southern G, Flowers L, Conrad L, Gordon A, Rodriguez L, Khanna N. Evaluating risk factors for surgical site infection following minimally invasive surgery for endometrial cancer. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
22
|
Cristea M, Frankel P, Synold T, Stewart D, Wang E, Jung A, Wilczynski S, Tran M, Konecny G, Eng M, Kilpatrick L, Chen YJ, Glaser S, Han E, Dellinger T, Hakim A, Lee S, Morgan R, Rodriguez L, Wakabayashi M. 863P A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in pts with selected FRα -positive solid tumours: Results in the endometrial cancer (EC) cohort. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
23
|
Selman-Geara A, Benitez-Camporro A, Defillo-Guerrero G, Ibrahim A, Redondo, Cytopathologist Y, Rodriguez L, Selman-Fermin A, Selman-Fermin AI. SAT-388 Dry Cough as Only Sign of a Parathyroid Adenoma Producer of PTH. J Endocr Soc 2020. [PMCID: PMC7208337 DOI: 10.1210/jendso/bvaa046.793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Abstract
BACKGROUND: The parathyroid adenoma producing an excess of PTH is characterized by hypercalcemia, asthenia, physical weakness and renal lithiasis. This clinical case is presented only with a dry (non-productive) cough sign of long duration.CASE: 51-year-old female born in Padre Las Casas, D.R. presenting with chief complain of dry cough for about four years. Clinical findings: (03/13/2019) Height 62”, Weight 142 lbs, Temperature 36.2 Celsius, BP 90/60 mmHg, RR 16 rpm, HR 60 bpm, on her neck no adenopathies or thyroid changes. Occasional coughing. A sonographic evaluation of the neck (04/09/2019) reveals a solid, heterogeneous nodular image of 0.7 cm x 0.5 cm in the left lobe of the Thyroid (Fig. 1) which by FNAB (04/10/2019) showed a benign adenomatoid node with cystic changes (Bethesda II) (Fig. 2). TEST: (03/20/2019) anti-TG 0.10 IU/mL (NV -115), anti-TPO 9.00 IU/mL (NV -34), TG 9.41 (NV -78 ng/mL), TSH 0.34 μIU/mL (VN 0.27-4.20), free T3 2.05 pg/mL (NV 2.04-4.40), total T3 0.74 ng/mL (NV 0.83-2.00), total T4 8.46 μg/dL (NV 5.1-14.1), free T4 1.61 ng/dL (NV 0.93-1.71) Calcium 10.4 mg/dL (NV 8.1-10.4), Phosphorus 2.6 mg/dL (NV 2.5-4.5), PTH-Intact 157 pg/mL (NV 14.5-87.1) Thyroid-Parathyroid scintigraphy (Sestamibi-Technetium 99mTc04: 15 mCi) (04/23/2019) shows lower left Parathyroid Adenoma (Fig. 3). She undergoes surgery (05/23/2019) removing the left thyroid lobe and left inferior parathyroid gland whose pathology shows chronic nodular colloid goiter, with areas of hemorrhage. Parathyroid adenoma of main cells (Fig. 4-5). Post-surgical TEST (06/24/2019) PTH-intact 69.0 pg/mL (NV 14.5-87.1), Calcium 8.6 mg/dL (NV 8.1-10.4), Phosphorus 2.7 mg/dL (NV 2.5-4.5), anti-TG 10.0 IU/mL (NV <115), anti-TPO 9.00 IU/mL (NV <34), TG 8.92 ng/mL (NV <78), total T3 0.68 ng/mL (NV 0.83-2.00), free T3 1.95 pg/mL (NV 2.04-4.40), total T4 6.40 μg/dL (NV 5.1-14.1), free T4 1.02 ng/dL (NV 0.93-1.71). Post-surgical clinical evaluation (06/21/2019) Weight 142 lbs, Temperature 36.5 Celsius, BP 110/70 mmHg, RR 16 rpm, HR 60 bpm. Patient has not shown signs of coughing. Last TESTS (10/20/2019) Calcium 9.40 mg/dL, Phosphorus 3.10 mg/dL, PTH-intact 24.40 pg/mL, TG 11.90 ng/mL, total T4 6.80 μg/dL, free T4 1.23 ng/dL, total T3 0.88 ng/mL, free T3 2.66 pg/mL, anti-TPO 11.14 IU/mL, anti-TG 10 IU/mL. CONCLUSIONS: Lower left (benign) parathyroid adenoma whose clinical manifestations are not common. Dry (non-productive) cough is not known as a manifestation of elevated PTH-intact. Calcium and Phosphorus levels in normal values. In addition, histological alterations of the left thyroid lobe of benign character with few manifestations of hormonal alterations and normal antibodies. It is of crucial clinical importance to observe and document more cases with similar presentation in order to identify the possible causes of cough with an elevated PTH manifestation.
Collapse
Affiliation(s)
| | | | | | - Ammar Ibrahim
- Universidad Central del Este, Santo Domingo, Dominican Republic
| | | | - L Rodriguez
- Clinica Dr. Abel Gonzalez, Santo Domingo, Dominican Republic
| | | | | |
Collapse
|
24
|
Coll R, Vidal J, Kumru H, Benito J, Valles M, Codinach M, Blanco M, Vives J, Querol S, Salvador F, Nogués N, Rodriguez L, Garcia J. Is HLA matching relevant for treating Spinal Cord Injury with intrathecal administration of expanded Wharton's Jelly Mesenchymal Stromal Cells? Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
25
|
Raffe S, Pollard A, Vera JH, Soni S, Peralta C, Rodriguez L, Dean G, Llewellyn CD. HIV self-tests for men who have sex with men, accessed via a digital vending machine: a qualitative study of acceptability. Int J STD AIDS 2020; 31:420-425. [PMID: 32188345 DOI: 10.1177/0956462419890726] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
As the number of people living with undiagnosed HIV infection in the UK declines, innovative ways to access those least engaged with services are needed. This study explores the attitudes of men who have sex with men (MSM) towards using HIV self-testing (HIVST) kits distributed via a vending machine in a sauna (a licenced sex-on-premise venue). Twenty-three MSM attending the sauna were recruited to take part in semi-structured qualitative interviews. The participants were overwhelmingly positive about the HIVST vending machine. They identified convenience and flexibility as major benefits to testing in this way. The sauna was felt to be an appropriate location for the intervention. Limitations identified included the potential to reduce screening for other sexually transmitted infections and the inappropriate use of HIVST kits as a tool for risk-assessment prior to condomless sex, with a poor understanding of the window period. The implications of receiving a positive result without immediate access to support were also a concern. HIVST vending machines are an acceptable, innovative way to encourage HIV testing. Providers need to ensure this intervention is supported by adequate information regarding the limitations of the test and how to access comprehensive services to avoid any unintended negative effects.
Collapse
Affiliation(s)
- S Raffe
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - A Pollard
- Department of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK
| | - J H Vera
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.,Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK
| | - S Soni
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - C Peralta
- Department of Design and Architecture, University of Brighton, Brighton, UK
| | | | - G Dean
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.,Martin Fisher Foundation, Brighton, UK
| | - C D Llewellyn
- Department of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK
| |
Collapse
|
26
|
Volpe K, Özel B, Nelken R, Stern M, Dancz C, Rodriguez L. 84: Knowledge of pelvic floor disorders within an underserved population. Am J Obstet Gynecol 2020. [DOI: 10.1016/j.ajog.2019.12.124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
27
|
Furlanetto Mançanares AC, Cabezas J, Rojas D, Manriquez J, Rodriguez L, Ovideo Castro F. 207 Editing of prostaglandin E2 gene receptors EP2 and EP4 by CRISPR/Cas9 technology in equine adipose mesenchymal stem cells. Reprod Fertil Dev 2020. [DOI: 10.1071/rdv32n2ab207] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Prostaglandin E2 (PGE2) is an important mediator of cellular responses, playing a key role in limiting inflammation. PGE2 acts distinctly through one of four EP receptors. In MSCs, it PGE2 stimulation of EP2 and EP4 receptors triggers processes such as migration, self-renewal, survival, and proliferation, and their activation is involved in homing. PGE2 has been proposed as a key factor of MSC immunomodulation. The CRISPR-Cas9 system has been adapted successfully to edit the genome of animals. Loss of EP2 and EP4 receptors in equine adipose mesenchymal stem cells (eAT-MSC) could help us understand their role in cell migration, homing, and self-renewal capacities. Here, we aimed to edit these receptors in eAT-MSC to test their function. The eAT-MSC were obtained from three Chilean breed horses and cultured in Dulbecco's modified Eagle's medium-high glucose with 10% fetal bovine serum. Guide RNAs (sgRNA) for CRISPR-Cas 9 editing were designed based on EP2 and EP4 DNA sequences. The sgRNA and PAM sequence targeting exon 1 of the equine genes (EP2-sgRNA: TGGTGCTGGCTTCGTACGCG; PAM:CGG and EP4-sgRNA: GGAGACGACCTTCTACACGT;PAM:TGG) were cloned into linearized LentiCRISPRv2GFP vector (#82416; Addgene). The lentiviral vector plus helping packaging plasmids was co-transfected into HEK293FT cells. The produced viral particles were harvested and transduced into eAT-MSC. After 48h, cells were sorted and green fluorescent protein (GFP)-positive cells were expanded to obtain individual clones. Genomic DNA was extracted for PCR amplification, and the frequency of site directed-mutation was assessed by T7 endonuclease assay. Because of the high background (e.g. excessive banding) produced by the T7E1 assay, the PCR products were cloned into a pUC57 vector, and sequenced. Quantitative PCR and immunocytochemistry staining examined expression of EP2 and EP4. The statistical analyses were performed using GraphPad Prism 6 (GraphPad Inc.) with unpaired t-test; P-values<0.05 were considered statistically significant. Transduction efficiency of eAT-MSC/EP2ko and eAT-MSC/EP4ko was 31 and 38%, respectively. A total of 15 clones for each lineage obtained from a single cell culture were subjected to T7EI assay to identify the frequency of mutation. Eight eAT-MSC/EP2ko and 7 eAT-MSC/EP4ko clones showed mutations; DNA sequencing confirmed mutations in 3 eAT-MSC/EP2ko clones and 3 eAT-MSC/EP4ko clones. Immunostaining with specific anti-EP2 and anti-EP4 antibodies showed diminished expression of the particular receptors in the knockout cells. Decreased expression was quantitatively confirmed by quantitative PCR analysis, showing downregulation of PTGER2 (4.3-fold) and PTGER4 (2.7-fold) in the edited clones compared with eAT-MSC naïve cells (P<0.05). This CRISPR/Cas9 design allows the possibility of using these mutant cell lines as a model system to elucidate the role of EP2 and EP4 in cell migration, homing, and self-renewal.
Research was supported by FONDECYT 3170390 to ACFM, Ministry of Education, Chile.
Collapse
|
28
|
Posso M, Canelo C, Niño de Guzman Quispe E, Rodriguez L, Pacheco K, Balbin Ramon G. CM1 EFECTIVIDAD Y SEGURIDAD DE LA RESECCIÃN MUCOSA ENDOSCÃPICA FRENTE A LA DISECCIÃN SUBMUCOSA EN PACIENTES CON CÃNCER GÃSTRICO TEMPRANO: REVISIÃN SISTEMÃTICA CON METANÃLISIS. Value Health Reg Issues 2019. [DOI: 10.1016/j.vhri.2019.08.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
29
|
Rodriguez L, Caro-Codon J, Rey-Blas JR, Rosillo SO, Gonzalez O, Martinez LA, Garcia De Veas JM, Casas B, Iniesta AM, Ruiz J, Rial V, Merino C, Armada E, Lopez-Sendon JL, Lopez-De-Sa E. P6471Pronostic impact of significant valvular disease in long-term survivors of out-of-hospital-cardiac arrest. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.1063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
There is scarce evidence about the prevalence and clinical relevance of moderate to severe valvular heart disease (VHD) in survivors of out of hospital cardiac arrest (OHCA).
Purpose
To determine whether VHD influence prognosis of OHCA survivors.
Methods
All consecutive patients admitted to the Acute Cardiac Care Unit after OHCA and surviving until hospital discharge were included. All patients received targeted-temperature management according to our local protocol. Univariate and multivariate Cox-proportional hazard models were employed.
Results
A total of 201 patients were included in the analysis. Mean age was 57.6±14.2 years and 168 (83.6%) were male. Eighteen patients (9.0%) had moderate or severe VHD during index admission (Table 1). Patients with VHD were less frequently of male sex, [11 (61.1%) vs 157 (85.8%), p=0.014], experienced less acute coronary syndrome-related arrhytmias [2 (11.1%) vs 85 (46.5%), p=0.005], and had a lower pH at hospital admission (6.9±1.6 vs 7.2±0.15, p=0.008). During a median follow-up of 40.3 (18.9–69.1) months, patients with VHD showed higher mortality [7 (38.9%) vs 28 (15.3%), p=0.004] and more heart failure-related admissions [7 (38.9%) vs 15 (8.2%), p<0.001]. Only five patients received surgical or percutaneous treatment for VHD during follow-up, with no deaths in this subgroup. Moderate or severe VHD proved to be an independent predictor of global cardiovascular events and specifically heart failure episodes (Figure 1).
Table1 Variable With valvular disease Without valvular disease p value Age, mean±DS, years 63.5±13.2 57.0±14.1 0.066 Hypertension, n (%) 12 (66.7) 95 (51.9) 0.231 Diabetes, n (%) 5 (27.8) 24 (13.1) 0.149 Dyslipidaemia, n (%) 7 (38.9) 79 (43.2) 0.726 Smokin habit, n (%) 4 (22.2) 90 (49.2) 0.045 Witnessed cardiac arrest, n (%) 18 (100) 175 (95.6) 1.000 Time from CA to ROSC, mean±DS, minute 19.1±7.5 21.2±13.1 0.506 Shockable rhythm, n (%) 13 (72.2) 163 (89.1) 0.055 LVEF at hospital discharge (%) 42.8±12.1 46.9±14.6 0.254
Figure 1
Conclusion
The presence of significant VHD in survivors after OHCA is a predictor of poor outcomes. Specific management of VHD may be specially relevant in this high-risk patients and guideline-oriented therapy, including surgery and percutaneous intervention should be encouraged when indicated.
Collapse
Affiliation(s)
- L Rodriguez
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - J Caro-Codon
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - J R Rey-Blas
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - S O Rosillo
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - O Gonzalez
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - L A Martinez
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | | | - B Casas
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - A M Iniesta
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - J Ruiz
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - V Rial
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - C Merino
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - E Armada
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - J L Lopez-Sendon
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - E Lopez-De-Sa
- University Hospital La Paz, Cardiology department, Madrid, Spain
| |
Collapse
|
30
|
Rodriguez L, Martinez LA, Rosillo SO, Martin L, Merino C, Marco I, Velez A, Caro-Codon J, Garcia De Veas JM, Iniesta AM, Rial V, Gonzalez O, Armada E, Lopez-Sendon JL, Lopez-De-Sa E. P5349Platelet/lymphocyte ratio as an inflammatory marker and predictor of short-term neurological outcomes in survivors after cardiac arrest. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Platelet/lymphocyte ratio (PLR), an inflammatory marker associated with poor outcomes in different clinical situations, may play a role in the proinflammatory state triggered during hypoxic-ischemic brain injury secondary to cardiac arrest.
Purpose
To study PLR dynamics and its relationship with neurologic outcomes in survivors after CA treated with target-temperature-management (TTM).
Methods
Observational retrospective study from a prospective database of survivors of in-hospital and out-of-hospital CA admitted to our Acute Cardiac Care Unit between August 2006 to December 2018. All patients received TTM according to our local protocol.
Results
A total of 466 patients were included. Mean age was 62.7±14.4 years and 102 (21.9%) were women. Baseline characteristics are shown in Table 1. 430 (92.2%) of CA were witnessed, 312 (67.0%) had ventricular fibrillation as initial cardiac rhythm. Among them, 236 (51.1%) survived until hospital discharge and 208 (45.1%) presented favorable neurological outcomes (a score 1 or 2 on cerebral performance category (CPC)). The mean value of PLR at admission and during targeted temperature was 100.4±5.2 and 224.5±7.3 respectively (mean difference 123.1±7.1, p<0.0001). This increase in PLR was significantly higher among patients with worse neurological outcomes (CPC 3–5, mean DPLR 138.2±5.5) at 3 months compared with survivors with CPC 1–2 (mean DPLR 108.2±6.3, p=0.0348 for paired comparison between both groups).
Table 1 Hypertension, n (%) 235 (54.9) Diabetes, n (%) 113 (26.4) Dyslipidaemia, n (%) 171 (40.0) Smocking habit, n (%) 208 (48.5) Time to ROSC mean ± SD, min 26.6±18.6 Mean arterial pressure at HA mean±DS, mmHg 81.3±22.1 pH at HA mean ± SD 7.18±0.16 Lactic at HA mean ± SD 6.37±4.42 ROSC: return of spontaneus circulation; HA: hospital admission.
Conclusion
Our findings reflect the impact of inflammation in neurological outcomes after OHCA treated with TTM. Major increases of PLR constitute a novel marker of poor prognosis during early assessment of OHCA patients.
Collapse
Affiliation(s)
- L Rodriguez
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - L A Martinez
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - S O Rosillo
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - L Martin
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - C Merino
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - I Marco
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - A Velez
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - J Caro-Codon
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | | | - A M Iniesta
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - V Rial
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - O Gonzalez
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - E Armada
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - J L Lopez-Sendon
- University Hospital La Paz, Cardiology department, Madrid, Spain
| | - E Lopez-De-Sa
- University Hospital La Paz, Cardiology department, Madrid, Spain
| |
Collapse
|
31
|
Gonzalez‐Cantero A, Carretero G, Rivera R, Ferrándiz C, Daudén E, Cueva P, Gómez‐García F, Belinchón I, Herrera‐Ceballos E, Ruiz‐Genao D, Ferrán M, Alsina M, Sánchez‐Carazo J, Baniandrés O, Sahuquillo‐Torralba A, Rodriguez L, Vilar J, García C, Carrascosa J, Llamas‐Velasco M, Herrera‐Acosta E, López‐Estebaranz J, Botella‐Estrada R, Descalzo M, García‐Doval I. Women with moderate‐to‐severe psoriasis in Spain (
BIOBADADERM
registry) show more than a 50% reduction in age‐adjusted fertility rate when compared with the general population. Br J Dermatol 2019; 181:1085-1087. [DOI: 10.1111/bjd.18164] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Fauste E, Aguirre R, Rodrigo S, Rodriguez L, Álvarez-Millán J, Panadero M, Otero P, Bocos C. Fructose Intake In Pregnancy Affects One-Carbon Metabolism Of Female Progeny. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
33
|
Dentamaro I, Valente F, Rodriguez L, Quijada A, Villalva N, Pineda V, Teixido G, Fernandez-Galera R, Ferreira I, Evangelista A, Cuellar H, Rdriguez-Palomares J. P185Evaluation of myocardial strain assessed by CMR tissue-tracking to predict adverse cardiovascular events in patients with cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez117.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- I Dentamaro
- Polyclinic Hospital of Bari, Cardiology Department, DETO, Bari, Italy
| | - F Valente
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Rodriguez
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Quijada
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - N Villalva
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - V Pineda
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - G Teixido
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - I Ferreira
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - H Cuellar
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | |
Collapse
|
34
|
Cabrera LO, Aguiar JO, Peix A, Padron K, Mena E, Escarano R, Carrillo R, Rodriguez L. P144Prognostic significance of perfusion and functional parameters from myocardial perfusion scintigraphy with positive ECG on stress test. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez147.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- L O Cabrera
- Institute of Cardiology, Nuclear Medicine, Havana, Cuba
| | - J O Aguiar
- Institute of Cardiology, Nuclear Medicine, Havana, Cuba
| | - A Peix
- Institute of Cardiology, Nuclear Medicine, Havana, Cuba
| | - K Padron
- Institute of Cardiology, Nuclear Medicine, Havana, Cuba
| | - E Mena
- Institute of Cardiology, Nuclear Medicine, Havana, Cuba
| | - R Escarano
- Institute of Cardiology, Nuclear Medicine, Havana, Cuba
| | - R Carrillo
- Institute of Cardiology, Nuclear Medicine, Havana, Cuba
| | - L Rodriguez
- Institute of Cardiology, Nuclear Medicine, Havana, Cuba
| |
Collapse
|
35
|
Flores J, Tan D, Reyna M, Calaguas M, Canedo J, Chiong E, Yu C, Rodriguez L, Marquez R. PO-141 The Effects of Biobran on Head and Neck Cancer Patients Undergoing Radiotherapy: A Double Blind RCT. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30307-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
36
|
Mançanares ACF, Manríquez JO, Cabezas J, Telleria F, Rodriguez L, Castro FO. 185 Overexpression or CRISPr/Cas9-mediated inhibition of prostaglandin E2 receptors EP2 and EP4 in equine adipose mesenchymal stem cells: implications for cell migration and cellular therapies. Reprod Fertil Dev 2019. [DOI: 10.1071/rdv31n1ab185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Prostaglandin E2 (PGE2) acts through 4 cellular receptors: EP1, EP2, EP3, and EP4; only EP2 and EP4 are relevant for immunomodulation and migration in immune cells. Besides those, several cells express these receptors on their surface, including mesenchymal stem cells. Pharmacological inhibition of the EP2 receptor prevents migration of immune system cells to inflamed sites, where the concentration of PGE2 is high. Based on this, we hypothesised that overexpression of EP2 or EP4 receptors in equine mesenchymal stem cells (eMSC) will improve their migration to inflammatory sites and subsequent homing capability. Conversely, their suppression will lead to low or no migration, favouring the paracrine properties of MSC in the processes of tissue regeneration and reduction of inflammation. To test this, we manipulated the PGE2-EP2-EP4 axis and evaluated the effect of such modifications on transgenic cells in vitro. Equine MSC from adipose tissue were obtained from 5 animals. The coding sequences of both receptors were synthesised (GenScript, Hong Kong) based on the published horse genome (National Center for Biotechnology Information; https://www.ncbi.nlm.nih.gov/) and cloned into pcDNA3.1 overexpression vectors (Addgene). The resulting constructs were lipofected into naïve adipose eMSC. For knockouts, we PCR-amplified and sequenced horse EP2 and EP4 receptors, and gRNAs were created based on the obtained sequences and ligated into LentiCRISPRV2 plasmid (Addgene, Cambridge, MA, USA). The lentiviral vector plus helping packaging plasmids were co-transfected into HEK293FT cells and the produced viral particles were harvested and transduced into adipose eMSC. After 48h of transfection (for overexpression) or transduction (for knockout, KO), cells were probed for the presence/absence of EP2 and EP4 receptors by immunohistochemistry and/or quantitative (q)PCR. Mitomycin-C-treated cells of both phenotypes and naïve, were subjected to migration in scratch assay, towards 3mM PGE2. Fetal calf serum (10 or 0%) was used as positive or negative control, respectively, in migration experiments. Receptors EP2 and EP4 were clearly overexpressed after transfection as determined by immunocytochemistry or qPCR assays (phenotype MSC-EP2+/EP4+), whereas in the cells that underwent KO, little or no expression of EP2 and EP4 was detected (phenotype MSC-EP2ko/EP4ko) compared with unmanipulated cells (naïve MSC-Ctr). In the migration experiments towards 3mM of PGE2, MSC-EP2+/EP4+ cells at 24h filled the scratch faster (P<0.05) than MSC-EP2ko/EP4ko or MSC-Ctr. These results showed that manipulation of PGE2-EP2/EP4 axis receptors led to changes in cell surface receptor availability and increased the migration pattern in overexpressed cells compared with KO and unmanipulated cells. These factors may affect the design of cellular therapeutic tools for inflammatory diseases in the equine species.
This research was supported by FONDECYT 3170390 to ACFM, Ministry of Education, Chile.
Collapse
|
37
|
Round WH, Ng KH, Rodriguez L, Thayalan K, Tang F, Srivastava R, Fukuda S, Krisanachinda A, Deng X, Han Y. AFOMP policy number 6: code of ethics for medical physicists in AFOMP Countries. Australas Phys Eng Sci Med 2018; 41:809-810. [PMID: 30406922 DOI: 10.1007/s13246-018-0708-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Accepted: 10/31/2018] [Indexed: 10/27/2022]
Abstract
This policy statement, which is the sixth of a series of documents prepared by the Asia-Oceania Federation of Organizations for Medical Physics (AFOMP) Professional Development Committee, gives guidance on how medical physicists in AFOMP countries should conduct themselves in an ethical manner in their professional practice (Ng et al. in Australas Phys Eng Sci Med 32:175-179, 2009; Round et al. in Australas Phys Eng Sci Med 33:7-10, 2010; Round et al. in Australas Phys Eng Sci Med 34:303-307, 2011; Round et al. in Australas Phys Eng Sci Med 35:393-398, 2012; Round et al. in Australas Phys Eng Sci Med 38:217-221, 2015). It was developed after the ethics policies and codes of conducts of several medical physics societies and other professional organisations were studied. The policy was adopted at the Annual General Meeting of AFOMP held in Jaipur, India, in November 2017.
Collapse
Affiliation(s)
- W H Round
- , 100 Te Awa Road, R D 3, 3283, Hamilton, New Zealand.
| | - K H Ng
- Department of Biomedical Imaging, University of Malaya, Kuala Lumpur, Malaysia
| | - L Rodriguez
- Jose R. Reyes Memorial Medical Center, Manila, Philippines
| | - K Thayalan
- Medical Physics Division, Dr Kamashi Memorial Hospital, Chennai, India
| | - F Tang
- Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, Hong Kong
| | - R Srivastava
- Department of Radiation Oncology, Ghent University Hospital, C. Heymanslaan 10, Radiotherapiepark, 9000, Ghent, Belgium
| | - S Fukuda
- Radiation Quality Control Section, Clinical Research Cluster, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan
| | - A Krisanachinda
- Department of Radiology, Chulalongkorn University, Bangkok, Thailand
| | - X Deng
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China
| | - Y Han
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea
| |
Collapse
|
38
|
Loncaric D, Labat V, Debeissat C, Brunet de la Grange P, Rodriguez L, Vlaski-Lafarge M, Ivanovic Z. The majority of cells in so-called "mesenchymal stem cell" population are neither stem cells nor progenitors. Transfus Clin Biol 2018; 26:316-323. [PMID: 30391125 DOI: 10.1016/j.tracli.2018.08.157] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2018] [Accepted: 08/18/2018] [Indexed: 01/05/2023]
Abstract
OBJECTIVES The first-passage adherent human bone marrow fibroblast-like cell population corresponds, in terms of phenotype and three-lineage differentiation capacity (assayed in bulk culture), to commonly termed "mesenchymal stem cells". Here we determine the proportion of high proliferative capacity multipotent cells present in this population in order to estimate the proportion of cells that can or cannot be considered as stem and progenitor cells. MATERIAL AND METHODS The single-cell cultures were established starting from human bone marrow-derived first-passage fibroblast-like cells and the proliferating clones were either transferred to secondary cultures to evaluate their further clonogenicity, or split into three wells to assess differentiation into each of the three different lineages. RESULTS The analysis of 197 single-cell cultures from three different bone marrow donors shows that only∼40% of so-called "mesenchymal stem cells" exhibit multipotency and are capable of sustained clonogenicity in secondary cultures. CONCLUSION Even in the first ex vivo passage under favorable conditions the majority (∼60%) of so-called "mesenchymal stem cells" are not multipotent and thus do not represent a stem cell entity.
Collapse
Affiliation(s)
- D Loncaric
- Établissement français du sang Nouvelle Aquitaine, scientific department, place Amélie-Raba-Léon, CS21010, 33075 Bordeaux cedex, France; Inserm U1035, université de Bordeaux, 33000 Bordeaux, France
| | - V Labat
- Établissement français du sang Nouvelle Aquitaine, scientific department, place Amélie-Raba-Léon, CS21010, 33075 Bordeaux cedex, France; Inserm U1035, université de Bordeaux, 33000 Bordeaux, France
| | - C Debeissat
- Établissement français du sang Nouvelle Aquitaine, scientific department, place Amélie-Raba-Léon, CS21010, 33075 Bordeaux cedex, France; Inserm U1035, université de Bordeaux, 33000 Bordeaux, France
| | - P Brunet de la Grange
- Établissement français du sang Nouvelle Aquitaine, scientific department, place Amélie-Raba-Léon, CS21010, 33075 Bordeaux cedex, France; Inserm U1035, université de Bordeaux, 33000 Bordeaux, France
| | - L Rodriguez
- Établissement français du sang Nouvelle Aquitaine, scientific department, place Amélie-Raba-Léon, CS21010, 33075 Bordeaux cedex, France; Inserm U1035, université de Bordeaux, 33000 Bordeaux, France
| | - M Vlaski-Lafarge
- Établissement français du sang Nouvelle Aquitaine, scientific department, place Amélie-Raba-Léon, CS21010, 33075 Bordeaux cedex, France; Inserm U1035, université de Bordeaux, 33000 Bordeaux, France
| | - Z Ivanovic
- Établissement français du sang Nouvelle Aquitaine, scientific department, place Amélie-Raba-Léon, CS21010, 33075 Bordeaux cedex, France; Inserm U1035, université de Bordeaux, 33000 Bordeaux, France.
| |
Collapse
|
39
|
Lalor N, Nau G, Rodriguez L, Dominguez Pace MP, Mitrione S, Costabel JP, Pedernera G, Spaletra P, Banos N, Trivi M. P6451Effect of prehospital catheterization laboratory activation on STEMI diagnosis - wire crossing time, ventricular ejection fraction and mortality. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- N Lalor
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - G Nau
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - L Rodriguez
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - M P Dominguez Pace
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - S Mitrione
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - J P Costabel
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - G Pedernera
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - P Spaletra
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - N Banos
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| | - M Trivi
- Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
| |
Collapse
|
40
|
Sato K, Sankaramangalam K, Krishnaswamy A, Mick S, Rodriguez L, Grimm R, Menon V, Kapadia S, Desai M, Svensson L, Griffin B, Popovic Z. 1139Prognostic impact of aortic valve replacement in contemporary low-gradient aortic stenosis patients with lack of contractile reserve. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.1139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- K Sato
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - K Sankaramangalam
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - A Krishnaswamy
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - S Mick
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - L Rodriguez
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - R Grimm
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - V Menon
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - M Desai
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - L Svensson
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - B Griffin
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - Z Popovic
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| |
Collapse
|
41
|
Cracknell L, Rodriguez L, McDaniel R, Xiangshan Z, Turner E, Annesi C, Chaozhong Z. PO-283 Characterisation of hTERT-immortalised prostate-derived stromal and epithelial cells: an authentic in vitro model for tumour microenvironment studies. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
42
|
Coll R, Vidal J, Kumru H, Benito J, Valles M, Ribó N, Codinach M, Blanco M, Gómez S, Vives J, Querol S, Rodriguez L, Garcia J. Intrathecal administration of expanded wharton's jelly mesenchymal stromal cells (WJ-MSC) in chronic traumatic spinal cord injury (SCI) (NCT03003364). Cytotherapy 2018. [DOI: 10.1016/j.jcyt.2018.02.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
43
|
Pach E, Rodriguez L, Verdaguer A. Substrate Dependence of the Freezing Dynamics of Supercooled Water Films: A High-Speed Optical Microscope Study. J Phys Chem B 2017; 122:818-826. [DOI: 10.1021/acs.jpcb.7b06933] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- E. Pach
- Catalan Institute
of Nanoscience and Nanotechnology (ICN2), CSIC and The Barcelona Institute
of Science and Technology, Campus UAB,
Bellaterra, 08193 Barcelona, Spain
| | - L. Rodriguez
- Catalan Institute
of Nanoscience and Nanotechnology (ICN2), CSIC and The Barcelona Institute
of Science and Technology, Campus UAB,
Bellaterra, 08193 Barcelona, Spain
| | - A. Verdaguer
- Institut de Ciència
de Materials de Barcelona ICMAB-CSIC, Campus de la UAB, E-08193 Bellaterra, Spain
| |
Collapse
|
44
|
Velez M, Baxter N, Rodriguez L, Lajkosz K, Korkidakis A, Green M. Hematological cancers in young women and subsequent infertility diagnosis: a population-based cohort study. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Singanallur NB, Pacheco JM, Arzt J, Stenfeldt C, Fosgate GT, Rodriguez L, Vosloo W. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep. Antiviral Res 2017; 145:114-122. [PMID: 28780422 DOI: 10.1016/j.antiviral.2017.07.020] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Revised: 06/30/2017] [Accepted: 07/31/2017] [Indexed: 11/26/2022]
Abstract
Potency tests for commercial oil-adjuvanted foot-and-mouth disease (FMD) vaccines are usually carried out in cattle, using a full dose (2 ml) of vaccine and homologous virus challenge. However, in sheep the recommended vaccine dose is half of the cattle dose (1 ml) and most vaccines have not been potency tested for this species, especially with heterologous viruses. To determine the efficacy of a high potency (>6PD50) FMD virus (FMDV) O1Manisa vaccine in sheep, we carried out a study using a heterologous FMDV (FMDV O/SKR/2010 - Mya-98 strain) challenge. Groups of seven animals each were vaccinated with 2×, 1×, 1/2× or 1/4× dose (2 ml, 1 ml, 0.5 ml or 0.25 ml respectively) and challenged at 7 days post vaccination (dpv). Only 3 of the 7 sheep in the group vaccinated with 2 ml were protected. With 2 additional groups, receiving double or single doses and challenged at 14 dpv, 4 of 7 sheep were protected in each group. None of the sheep had measurable neutralising antibodies against the vaccine or challenge virus at 7 dpv. However, all vaccinated animals challenged at 14 dpv had a homologous neutralising response against FMDV O1 Manisa on the day of challenge and all but one animal also had a heterologous response to FMDV O/SKR/2010. Infectious FMDV and viral RNA could be found in nasal swabs between 1 and 6 days post challenge (dpc) in most vaccinated sheep, but those vaccinated with higher doses or challenged at 14 dpv showed significant decreases in the level of FMDV detection. Intermittent virus shedding was noticed between 1 and 35 dpc in all vaccinated groups, but persistent infection could be demonstrated only in 4 sheep (20%). This study showed that at the recommended dose, a high potency (>6 PD50) FMDV O1Manisa vaccine does not protect sheep against a heterologous challenge at 7 dpv. However, partial protection was observed when a double dose was used at 7 dpv or when double or single dose vaccinated sheep were challenged at 14 dpv.
Collapse
Affiliation(s)
- N B Singanallur
- Australian Animal Health Laboratory, CSIRO-Health and Biosecurity, Geelong, Australia
| | - J M Pacheco
- Plum Island Animal Disease Center, USDA-ARS, Orient Point, New York, USA
| | - J Arzt
- Plum Island Animal Disease Center, USDA-ARS, Orient Point, New York, USA
| | - C Stenfeldt
- Plum Island Animal Disease Center, USDA-ARS, Orient Point, New York, USA
| | - G T Fosgate
- Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa
| | - L Rodriguez
- Plum Island Animal Disease Center, USDA-ARS, Orient Point, New York, USA
| | - W Vosloo
- Australian Animal Health Laboratory, CSIRO-Health and Biosecurity, Geelong, Australia.
| |
Collapse
|
46
|
Huded C, Kusunose K, Goodman A, Alashi A, Shahid F, Grimm R, Gillinov A, Johnston D, Rodriguez L, Svensson L, Griffin B, Desai M. P187Long-term mortality after surgical aortic valve replacement in patients with normal left ventricular systolic function: incremental utility of valvuloarterial impedence and left ventricular strain. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Shah S, Alashi A, Pettersson G, Rodriguez L, Gillinov M, Grimm R, Navia J, Kapadia S, Svensson L, Griffin B, Desai M. 4111Outcomes of paravalvular leak after aortic and mitral valve surgery. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.4111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
48
|
Vega E, Parodi J, Menendez J, Rodriguez L. IMPROVING LEADERSHIP COMPETENCIES IN PUBLIC HEALTH AND AGING: THE LATIN AMERICA EXPERIENCE. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- E. Vega
- Life Course, Pan American Health Organization (PAHO), Washington, District of Columbia,
| | - J. Parodi
- University of San Martin de Porres, Lima, Peru,
| | - J. Menendez
- Centro Colaborador OPS-OMS en Salud Publica y Envejecimiento, La Habana, Cuba,
| | | |
Collapse
|
49
|
Möstl C, Isavnin A, Boakes PD, Kilpua EKJ, Davies JA, Harrison RA, Barnes D, Krupar V, Eastwood JP, Good SW, Forsyth RJ, Bothmer V, Reiss MA, Amerstorfer T, Winslow RM, Anderson BJ, Philpott LC, Rodriguez L, Rouillard AP, Gallagher P, Nieves-Chinchilla T, Zhang TL. Modeling observations of solar coronal mass ejections with heliospheric imagers verified with the Heliophysics System Observatory. Space Weather 2017; 15:955-970. [PMID: 28983209 PMCID: PMC5601179 DOI: 10.1002/2017sw001614] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/22/2017] [Revised: 05/18/2017] [Accepted: 06/30/2017] [Indexed: 06/07/2023]
Abstract
We present an advance toward accurately predicting the arrivals of coronal mass ejections (CMEs) at the terrestrial planets, including Earth. For the first time, we are able to assess a CME prediction model using data over two thirds of a solar cycle of observations with the Heliophysics System Observatory. We validate modeling results of 1337 CMEs observed with the Solar Terrestrial Relations Observatory (STEREO) heliospheric imagers (HI) (science data) from 8 years of observations by five in situ observing spacecraft. We use the self-similar expansion model for CME fronts assuming 60° longitudinal width, constant speed, and constant propagation direction. With these assumptions we find that 23%-35% of all CMEs that were predicted to hit a certain spacecraft lead to clear in situ signatures, so that for one correct prediction, two to three false alarms would have been issued. In addition, we find that the prediction accuracy does not degrade with the HI longitudinal separation from Earth. Predicted arrival times are on average within 2.6 ± 16.6 h difference of the in situ arrival time, similar to analytical and numerical modeling, and a true skill statistic of 0.21. We also discuss various factors that may improve the accuracy of space weather forecasting using wide-angle heliospheric imager observations. These results form a first-order approximated baseline of the prediction accuracy that is possible with HI and other methods used for data by an operational space weather mission at the Sun-Earth L5 point.
Collapse
Affiliation(s)
- C Möstl
- Space Research Institute Austrian Academy of Sciences Graz Austria
- IGAM-Kanzelhöhe Observatory, Institute of Physics University of Graz Graz Austria
| | - A Isavnin
- Department of Physics University of Helsinki Helsinki Finland
| | - P D Boakes
- Space Research Institute Austrian Academy of Sciences Graz Austria
- IGAM-Kanzelhöhe Observatory, Institute of Physics University of Graz Graz Austria
| | - E K J Kilpua
- Department of Physics University of Helsinki Helsinki Finland
| | - J A Davies
- RAL Space Rutherford Appleton Laboratory Harwell UK
| | - R A Harrison
- RAL Space Rutherford Appleton Laboratory Harwell UK
| | - D Barnes
- RAL Space Rutherford Appleton Laboratory Harwell UK
- University College London London UK
| | - V Krupar
- Institute of Atmospheric Physics CAS Prague Czech Republic
| | - J P Eastwood
- Blackett Laboratory Imperial College London London UK
| | - S W Good
- Blackett Laboratory Imperial College London London UK
| | - R J Forsyth
- Blackett Laboratory Imperial College London London UK
| | - V Bothmer
- Institute for Astrophysics University of Göttingen Göttingen Germany
| | - M A Reiss
- IGAM-Kanzelhöhe Observatory, Institute of Physics University of Graz Graz Austria
| | - T Amerstorfer
- Space Research Institute Austrian Academy of Sciences Graz Austria
| | - R M Winslow
- Institute for the Study of Earth, Oceans, and Space University of New Hampshire Durham New Hampshire USA
| | - B J Anderson
- Applied Physics Laboratory The Johns Hopkins University Laurel Maryland USA
| | - L C Philpott
- Department of Earth, Ocean and Atmospheric Sciences University of British Columbia Vancouver British Columbia Canada
| | - L Rodriguez
- Solar Terrestrial Center of Excellence-SIDC Royal Observatory of Belgium Brussels Belgium
| | - A P Rouillard
- Institut de Recherche en Astrophysique et Planétologie Université de Toulouse (UPS) Toulouse France
- Centre National de la Recherche Scientifique Toulouse France
| | - P Gallagher
- School of Physics Trinity College Dublin Ireland
| | | | - T L Zhang
- Space Research Institute Austrian Academy of Sciences Graz Austria
| |
Collapse
|
50
|
Bansal N, Hampe CS, Rodriguez L, Smith EO, Kushner J, Balasubramanyam A, Redondo MJ. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes. Diabet Med 2017; 34:641-646. [PMID: 26802570 PMCID: PMC4958605 DOI: 10.1111/dme.13077] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/19/2016] [Indexed: 12/18/2022]
Abstract
AIM To study whether DPD epitope-specific glutamate decarboxylase autoantibodies are found more frequently in children with milder forms of Type 1 diabetes. METHODS We prospectively evaluated 75 children with new-onset autoimmune Type 1 diabetes, in whom we collected demographic, anthropometric and clinical data and measured islet autoantibodies. Glutamate decarboxylase 65 autoantibody-positive samples were analysed for epitope specificities using recombinant Fab against the DPD-defined epitope of glutamate decarboxylase 65. RESULTS After adjustment for age, positive DPD epitope recognition was significantly associated with higher C-peptide levels at onset (P = 0.02, r2 =0.21, n = 35), and high DPD recognition in the highest quartile tended to be associated with HbA1c ≤ 53 mmol/mol (7%) at the last follow-up [mean (sd) follow-up 1.3 (0.4) years; P = 0.07; for the model, P = 0.044, n = 30)]. Age- and sex-adjusted BMI percentile was significantly correlated with recognition of the DPD-defined epitope (P < 0.03, r2 =0.14, n = 34), but this correlation was driven by the older age group (age ≥ 10 years; P = 0.016, r2 =0.27, n = 21) and was not significant in younger children (P = 0.93, n = 13). There were no independent associations with sex, race/ethnicity, diabetic ketoacidosis, HbA1c , HLA DR3-DQ2/DR4-DQ8 or autoantibody number. CONCLUSIONS Our findings suggest that recognition of the DPD-defined glutamate decarboxylase 65 autoantibody epitope at Type 1 diabetes onset is directly associated with β-cell function, BMI and age, which supports the hypothesis that immunological factors contribute to the clinical heterogeneity of Type 1 diabetes. Larger studies relating epitope-specific glutamate decarboxylase 65 autoantibody to clinical phenotype in children with Type 1 diabetes are warranted.
Collapse
Affiliation(s)
- N. Bansal
- Department of Pediatrics, Section of Diabetes and Endocrinology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX
| | - C. S. Hampe
- Department of Medicine, University of Washington, Seattle, WA
| | - L. Rodriguez
- Department of Pediatrics, Section of Pediatric Endocrinology, Children’s Hospital of San Antonio, Baylor College of Medicine, San Antonio, TX
| | - E. O’Brian Smith
- Children’s Nutrition Research Center, Baylor College of Medicine, Houston, TX
| | - J. Kushner
- Department of Pediatrics, Section of Diabetes and Endocrinology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX
| | - A. Balasubramanyam
- Translational Metabolism Unit, Diabetes Research Center, Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, USA
| | - M. J. Redondo
- Department of Pediatrics, Section of Diabetes and Endocrinology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX
| |
Collapse
|